Beyond inhibiting proangiogenic cytokines (in whichever form or in whatever combination) to reverse neovascular AMD, a current pipeline of translational endeavours are focussed on the role of inflammation, with the emphasis on redressing complement dysregulation or via inhibiting the assumed negative impact of chronic low-grade inflammation such as inflammasome activation. However, and not ignoring the complexity and as yet ill-defined underlying immunobiology, there is compelling contrary evidence that altered immune responses (increasing with age) provide an ability to maintain and preserve tissue function.
